Suppr超能文献

[类风湿关节炎中的骨质疏松症]

[Osteoporosis in rheumatoid arthritis].

作者信息

Haugeberg G

机构信息

Revmatologisk avdeling, Vest-Agder Sentralsykehus, Kristiansand S.

出版信息

Tidsskr Nor Laegeforen. 1997 Feb 20;117(5):651-4.

PMID:9102954
Abstract

In cases of rheumatoid arthritis, osteoporosis may be local or general. The aetiology is multifactorial. Reduced bodily function, synovial inflammation, steroids and menopause are important risk factors. Studies have shown that, in cases of primary osteoporosis, bone mineral density measurements in the distal radius may predict risk of fracture at other sites, such as the neck of the femur and the dorsal vertebrae. Such a connection is not found for rheumatoid arthritis. Bone density measurements in the distal radius may overestimate the risk of fractures due to localised periarticular osteoporosis. Overall bone quality is assumed to be poorer, however, in patients with rheumatoid arthritis, leading to higher risk of fracture than the bone mineral density measurements seem to show. Data are lacking on the effect of antiresorptive drugs on this condition. Treatment with oestrogen and the bisphosphonate pamidronate has been shown to increase bone mineral density. Data are lacking on fractures. As shown in the case of primary osteoporosis, decreased risk of fracture is to be expected also in patients with secondary osteoporosis.

摘要

在类风湿性关节炎病例中,骨质疏松可能是局部性的或全身性的。其病因是多因素的。身体功能下降、滑膜炎症、类固醇和绝经是重要的风险因素。研究表明,在原发性骨质疏松病例中,桡骨远端的骨密度测量可预测其他部位(如股骨颈和胸椎)的骨折风险。类风湿性关节炎未发现这种关联。桡骨远端的骨密度测量可能会因局部关节周围骨质疏松而高估骨折风险。然而,类风湿性关节炎患者的整体骨质量被认为较差,导致骨折风险高于骨密度测量结果所显示的。关于抗吸收药物对这种情况的影响的数据尚缺乏。雌激素和双膦酸盐帕米膦酸治疗已显示可增加骨密度。关于骨折的数据尚缺乏。如原发性骨质疏松病例所示,继发性骨质疏松患者的骨折风险也有望降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验